{"version":"1.0","type":"link","title":"Durable Disease Control by RET Inhibitor Selpercatinib in a Heavily Pre-Treated RET Fusion-Positive Papillary Thyroid Cancer.","author_name":"Yokota T 외","author_url":"https://prs-insight.online/author/Yokota%20T","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/147335","thumbnail_width":1200,"thumbnail_height":630}